In recent years, the S100B protein has been largely emphasized as the biochemical marker of cerebral diseases [18], and there are experimental animal studies demonstrate that S100B proteins induce similar intermittent hypoxia-associated neuronal degeneration as that seen in OSA [19]. This evidence concerns the gene S100B and obstructive sleep apnea syndrome.